LATONJA SHAW: Open Payments
NPI 1063885515 · MESQUITE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 84 payments from 24 companies in 2025. Trend: 2023 $1,784 · 2024 $1,576 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $300 |
| AstraZeneca Pharmaceuticals LP | 5 | $191 |
| Lilly USA, LLC | 9 | $155 |
| GlaxoSmithKline, LLC. | 10 | $149 |
| Novo Nordisk Inc | 6 | $129 |
| Antares Pharma, Inc. | 6 | $106 |
| Amgen Inc. | 5 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Exact Sciences Corporation | 2 | $56 |
| Corcept Therapeutics | 1 | $48 |
Products named: JARDIANCE, PREVNAR 20, BREZTRI, Ozempic, XYOSTED, TRELEGY ELLIPTA, ELIQUIS, Korlym.
Industry payments across TX — which companies pay providers there.
